Our findings corroborate previous reports by us and others, demonstrating the critical but opposite functions of YY1 and RKIP in the regulation of tumor sensitivities to drug and endogenous immune-mediated cytotoxic effects and/or immunotherapy [8,90,95,114]. Here, YY1 is linked to neoplasm.